We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00610467
First Posted: February 8, 2008
Last Update Posted: December 8, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Min-Ying (Lydia) Su, University of California, Irvine
January 12, 2008
February 8, 2008
December 8, 2016
October 2006
October 2016   (Final data collection date for primary outcome measure)
To prove that combined optical/MRI imaging system can enhance the diagnostic specificity compared to that using MRI alone. [ Time Frame: at completion of this study ]
Same as current
Complete list of historical versions of study NCT00610467 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis
Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis
This study will investigate whether adding the optical imaging to magnetic resonance imaging can improve the diagnostic specificity of breast cancer.
Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Breast Cancer
Device: combined optical and MR imaging
MRI contrast agent (0.1 mmol/kg) optical contrast agent ICG (0.5 mg/kg)
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
120
Not Provided
October 2016   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. A female older than 21 years of age,
  2. Have suspicious imaging findings suggesting a possibility of breast cancer, or biopsy-proven breast cancer.

Exclusion Criteria:

  1. Pregnant,
  2. Unwilling to give informed consent,
  3. Have implanted prosthetic heart valves, pacemaker, neuro-stimulation devices, surgical clips (hemostatic clips) or other metallic implants,
  4. Have engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or have imbedded metal fragments from military activities,
  5. Have received orthodontic work involving ferromagnetic materials,
  6. Claustrophobic,
  7. Have had allergic response to contrast agents (such as iodine or gadolinium) previously,
  8. Have known history of severe renal insufficiency, asthma, allergic conditions, sickle cell anemia, chronic hemolytic anemia, and gastrointestinal disorders.
Sexes Eligible for Study: Female
21 Years to 90 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00610467
UCI-HS-2006-5162
NIH-CA121568
No
Not Provided
Not Provided
Min-Ying (Lydia) Su, University of California, Irvine
University of California, Irvine
Not Provided
Principal Investigator: Min-Ying Su, PhD University of California, Irvine
University of California, Irvine
December 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP